Birgitta Gullstrand
1 – 10 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
- Contribution to journal › Article
-
Mark
Neutralizing autoantibodies against interferon alpha in systemic lupus erythematosus : Prevalence, age of onset, and clinical associations
- Contribution to journal › Article
- 2025
-
Mark
Data-Driven Cluster Analysis of Cerebrospinal Fluid Proteome and Associations with Clinical Phenotypes in Systemic Lupus Erythematosus
- Contribution to journal › Article
- 2024
-
Mark
Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
- Contribution to journal › Article
- 2023
-
Mark
Plasmanivåer av osteopontin hos patienter med SLE kan prediktera risken för nefrit
(2023) Reumadagarna
- Contribution to conference › Poster
- 2022
-
Mark
Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study
- Contribution to journal › Article
-
Mark
Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
- Contribution to journal › Article
-
Mark
Plasma levels of osteopontin in SLE
- Contribution to journal › Published meeting abstract
-
Mark
Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus
- Contribution to journal › Article
-
Mark
PLASMA LEVELS OF OSTEOPONTIN IN SLE
(2022) 13th European Lupus Meeting
- Contribution to conference › Poster
